Jaimini Cegla
HEART UK consensus statement on Lipoprotein(a): A call to action
Cegla, Jaimini; Neely, R Dermot G; France, Michael; Ferns, Gordon; Byrne, Chris D; Halcox, Julian; Datta, Dev; Capps, Nigel; Shoulder, Carol; Qureshi, Nadeem; Rees, Alan; Main, Linda; Cramb, Robert; Viljoen, Adie; Paynel, Jules; Soran, Handrean; for the HEART UK Medical, Scientific and Research Committee
Authors
R Dermot G Neely
Michael France
Gordon Ferns
Chris D Byrne
Julian Halcox
Dev Datta
Nigel Capps
Carol Shoulder
Professor NADEEM QURESHI nadeem.qureshi@nottingham.ac.uk
CLINICAL PROFESSOR
Alan Rees
Linda Main
Robert Cramb
Adie Viljoen
Jules Paynel
Handrean Soran
for the HEART UK Medical, Scientific and Research Committee
Abstract
Lipoprotein(a), Lp(a), is a modified atherogenic low-density lipoprotein particle that contains apolipoprotein(a). Its levels are highly heritable and variable in the population. This consensus statement by HEART UK is based on the evidence that Lp(a) is an independent cardiovascular disease (CVD) risk factor, provides recommendations for its measurement in clinical practice and reviews current and emerging therapeutic strategies to reduce CVD risk. Ten statements summarise the most salient points for practitioners and patients with high Lp(a).
HEART UK recommends that Lp(a) is measured in adults as follows: 1) those with a personal or family history of premature atherosclerotic CVD; 2) those with first-degree relatives who have Lp(a) levels >200 nmol/l; 3) patients with familial hypercholesterolemia; 4) patients with calcific aortic valve stenosis and 5) those with borderline (but
Citation
Cegla, J., Neely, R. D. G., France, M., Ferns, G., Byrne, C. D., Halcox, J., Datta, D., Capps, N., Shoulder, C., Qureshi, N., Rees, A., Main, L., Cramb, R., Viljoen, A., Paynel, J., Soran, H., & for the HEART UK Medical, Scientific and Research Committee. (2019). HEART UK consensus statement on Lipoprotein(a): A call to action. Atherosclerosis, 291, 62-70. https://doi.org/10.1016/j.atherosclerosis.2019.10.011
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 10, 2019 |
Online Publication Date | Oct 14, 2019 |
Publication Date | 2019-12 |
Deposit Date | Oct 11, 2019 |
Publicly Available Date | Nov 12, 2019 |
Journal | Atherosclerosis |
Print ISSN | 0021-9150 |
Electronic ISSN | 1879-1484 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 291 |
Pages | 62-70 |
DOI | https://doi.org/10.1016/j.atherosclerosis.2019.10.011 |
Keywords | Lipoprotein(a), Lp(a), lipid, hyperlipidemia, cardiovascular risk, myocardial infarction, stroke. |
Public URL | https://nottingham-repository.worktribe.com/output/2806978 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S002191501931528X |
Contract Date | Oct 11, 2019 |
Files
Cegla Atherosclerisis 2019
(671 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search